| Text of Recommendation | CMS should educate enrollees and providers about options for access to overdose-reversal
medications, as Narcan and its generic equivalents will no longer be covered by Part D. |
|---|---|
| Recommendation Number | 24-E-02-005.01 |
| Recommendation Status | Open |
| Significant Recommendation | No |
| Recommendation Questioned Costs | $0 |
| Recommendation Funds for Better Use | $0 |
| Submitting OIG | |
|---|---|
| Report Title | The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern |
| Report Submitting OIG-Specific Report Number | OEI-02-23-00250 |
| Report Date Issued | Monday, December 11, 2023 |
| Report Agency Reviewed / Investigated | |
| Report Questioned Costs | $0 |
| Report Funds for Better Use | $0 |